Showing 71-80 of 2293 results for "".
As Treatment Options Expand, Researchers Continue to Explore the Basis of MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/as-treatment-options-expand-researchers-continue-to-explore-the-basis-of-ms/30601/New treatments have emerged and others are expected. What have changes meant for patient care?Patient Expectations, Market Predictions Focus on Oral MS Drugs
https://practicalneurology.com/columns/practice-management/patient-expectations-market-predictions-focus-on-oral-ms-drugs/30711/ACTRIMS 2016 Forum Coverage: Updates in MS Therapeutics and Research
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/actrims-2016-forum-coverage-updates-in-ms-therapeutics-and-research/30481/MS Minute: Late-Breaking Data From ECTRIMS—Evobrutinib Safety and Efficacy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-late-breaking-data-from-ectrimsevobrutinib-safety-and-efficacy/30164/A potential new first-in-class treatment affects Bruton's tyrosine kinase.Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
https://practicalneurology.com/programs/cme/personalized-care-for-diverse-ms-populations-special-populations-equal-special-care/32231/Tune in to learn more about the use of high-efficacy DMTs in multiple sclerosis.Seeking Breakthroughs: The Industry Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-industry-perspective/30192/A roundtable discussion with Gregory Went, PhD, Adamas Pharmaceuticals; Lynn Kramer, MD, Eisai; Paulo Fontoura, MD, PhD, Genentech/Roche; Justin Gover, BSc, MBA, GW Pharmaceuticals; Marc Kamin, MD, SK Life Sciences; and Mike Davis, BSc, MBA, UCBMultiple Sclerosis--Is it One Disease or Many Diseases?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-is-it-one-disease-or-many-diseases/30103/Dr. Stephen Krieger will share his view that MS is one disease state while Dr. Bianca Weinstock-Guttman challenges that view, arguing that MS is many disease states.The Importance of Early Diagnosis and Treatment of Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-importance-of-early-diagnosis-and-treatment-of-alzheimer-disease/35436/Linda Shows, a semi-retired nurse who lives with mild cognitive impairment, and her physician, Wendell Helveston, MD, Hattiesburg Clinic, Hattiesburg, MS, discuss the importance of early diagnosis and treatment in Alzheimer disease, including other factors that can help patients thrive when living w- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31238/Differentiating Multiple Sclerosis (MS) from Sjögren’s Syndrome (SS) is critical due to overlapping neurological manifestations and distinct treatment pathways. A clinical case of a 49-year-old woman presenting with ataxia and band-like paresthesias initially suggests MS, supported by MRI findings o
A Treatment Within
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/a-treatment-within/30713/A small Phase I trial sees success using patients' own altered blood cells to fight immune responses in MS. Is this the future of MS therapy?